This chapter describes the use of glutathione S-transferase (GST) gene fusion proteins as a method for inducible, high-level protein expression and purification from bacterial cell lysates. The protein is expressed in a pGEX vector, with the GST moiety located at the N-terminus followed by the target protein. The use of GST as a fusion tag is desirable because it can act as a chaperone to facilitate protein folding, and frequently the fusion protein can be expressed as a soluble protein rather than in inclusion bodies. Additionally, the GST fusion protein can be affinity purified facilely without denaturation or use of mild detergents. The fusion protein is captured by immobilized glutathione and impurities are washed away. The fusion protein then is eluted under mild, non-denaturing conditions using reduced glutathione. If desired, the removal of the GST affinity tag is accomplished by using a site-specific protease recognition sequence located between the GST moiety and the target protein. Purified proteins have been used successfully in immunological studies, structure determinations, vaccine production, protein-protein, and protein-DNA interaction studies and other biochemical analysis.
Introduction
Glutathione S-transferase (GST) is a naturally occurring 26 KDa protein found in eukaryotic cells. The gene from the parasitic helminth Schistosoma japonicum was used in the development of the pGEX vectors (1). This unit describes the use of a GST affinity tag to aid in the purification of recombinant proteins. The 26KDa GST moiety binds with high affinity to glutathione coupled to a Sepharose matrix. This binding is reversible and the protein can be eluted under mild, non-denaturing conditions by the addition of reduced glutathione to the elution buffer. A specific protease site engineered between the GST moiety and the protein of interest allows removal of the GST moiety from the target recombinant protein. The GST can be removed from the sample by re-chromatography on a glutathione column, and the protein of interest purified to homogeneity by other techniques such as gel filtration or ion exchange. The most commonly used vectors are available from GE Healthcare (and are discussed here), although variations from other suppliers also are available.
Proteins produced using the GST fusion system have been used in numerous biological applications. The use of GST fusion proteins has been successful in both NMR and crystallography structure determinations. Generally, the GST tag is removed prior to these determinations, but several crystal structures exist for fused protein (2, 3) . Other applications include the study of protein-protein interactions via GST pull-down assays (4) . Proteins purified using the GST system also have been used successfully in immunological studies and vaccine production (5) . Recently, high-throughput proteomics studies have used GST fusion proteins for directional immobilization in protein microarrays (6) and surface plasmon resonance (7) . Successful structure-function studies involving protein-protein and DNA-protein interactions also have been described (8) .
Successful purification of GST fusion proteins requires several strategic decisions and may require optimization of methods and conditions for specific proteins. A flow diagram highlighting the basic steps of the vector design, expression and purification processes and some of the key decisions to be made is shown in Figure 1 . Each step involves multiple options that are often interrelated and could affect the final product yield and purity. For instance, choice of vector will be influenced by whether the GST moiety ultimately will be cleaved away from the target protein and the desired protease to be used. Something to consider when evaluating whether or not to cleave the GST moiety away is that GST is a homodimeric protein. If it is suspected that oligomeric state will influence properties of the target protein, the GST moiety should be cleaved away. Once a vector has been chosen and successful cloning has occurred, optimization of protein expression conditions such as E. coli host cell strain, temperature, concentration of IPTG, and length of induction should be optimized. Sample extraction usually is performed with sonication or French Press; however, some proteins may require more gentle extraction techniques. Several immobilized glutathione Sepharose media are available for use in the purification. Products in lab packs contain bulk resin that can be used in a batch-binding mode or with low-pressure chromatography columns that utilize gravity flow or a peristaltic pump; 96-well filter plates provide a convenient method for high-throughput screening; and prepacked HiTrap and HiPrep columns can be used with a medium-pressure chromatography system (.e.g. FPLC), peristaltic pump, or a syringe. Purification media choice largely depends on ultimate use of the protein and the scale of the purification and convenience of the product choices. Detection with SDS-PAGE will give information on sample size and purity, throughout the expression and purification procedure. In cases of low product yield, Western blotting can be used to detect the expressed protein. Cleavage of the target protein from the GST moiety will depend on the vector chosen and can be performed either in solution or while the protein is bound to the column. The enzyme should be inactivated and/or removed from the sample after cleavage. Depending on the sample purity required for ultimate use, the protein should be further purified after removal of the GST moiety using gel filtration, ion exchange, or other purification schemes.
Here we provide a detailed description of the protocols required for successful purification of GST fusion proteins, with an emphasis on maintaining the solubility of the fusion protein and avoiding denaturants or mild detergents. The protocols include basic information on the choice of expression vectors and host E. coli cells, detailed procedures for protein expression and purification of expressed protein, enzymatic cleavage of the GST moiety from the target protein, and subsequent steps to purify the target protein to homogeneity (see Note 1).
1 Detailed protocols and troubleshooting tips for all aspects of the GST gene fusion protein expression system are available from GE Healthcare in the handbooks: GST Gene Fusion System, product number 18-1157-58, and The Recombinant Protein Handbook, product number 18-1142-75. The handbooks are available for purchase in hard copy or can be accessed as a PDF on the GE Healthcare website.
Enzymatic cleavage to remove GST affinity tag

pGEX gene fusion construction
There are multiple pGEX gene fusion vectors available from GE Healthcare. A shared characteristic of all the vectors include the presence of a tac promoter for chemically inducible, high-level protein expression with IPTG. An internal laqI q gene helps to maintain tight control over expression of the insert by binding to the tac promoter until induction with IPTG. The available fusion vectors are designed so that the polypeptide of interest can be inserted immediately after the GST gene using a polylinker site (see Figure 2 ). A protease cleavage site is located between the GST sequence and the polylinker site so that the GST moiety can be enzymatically removed, if desired. Although not depicted in the vector diagram for all the different vectors, the polylinker sites are followed by stop codons in each reading frame. Although expression in E. coli is simple, economical, and efficient, it should be noted E. coli do not posttranslationally modify most proteins. If posttranslational modifications are required for function, expression in baculovirus (9) and yeast (10) have also been successful.
Choosing an appropriate vector is based on the ultimate use of the protein. If the GST moiety is to be cleaved away from the protein of interest, the pGEX-T series contains a protease cleavage site for thrombin, the pGEX-X series of vectors contain protease cleavage sites for factor Xa, and the pGEX-P series contains a cleavage site for PreScission protease (see Figure 2 ). When selecting the protease cleavage site, be sure that the protein of interest does not contain an internal recognition sequence for this protease. One of the advantages of using the thrombin recognition site is that it is generally cost effective, as relatively small 5 Addition of protease inhibitors to the lysis buffer will help to prevent proteolytic degradation of the target protein during extraction. However, the exact cocktail of protease inhibitors added to the lysis buffer should be tailored to the characteristics of the target protein. Reducing agents such as 2-ME, DTT, or TCEP at concentrations of 1-10 mM should be added to the buffer as needed. Addition of a nonionic detergent, such as 1% Triton X-100, also may be added to the buffer to aid in extraction. amounts of thrombin and short incubation times at 37 °C are sufficient to cleave the protein with high efficiency. Factor Xa has very high specificity, but is expensive and generally requires high enzyme-to-substrate ratios for efficient cleavage. PreScission protease is exclusive to GE Healthcare but has several advantageous characteristics, namely it is effective at low temperature (5 °C) and it is also a GST fusion protein, thereby facilitating removal after cleavage. An additional factor to consider when selecting a vector and the restriction sites that will be utilized is the sequence that remains at the N-terminus of the protein after removal of the GST moiety.
In this protocol, a set of oligonucleotides, including the appropriate restriction sites, are used to amplify the target gene by PCR. Detailed descriptions of the preparation of the cDNA inserts and creation of the gene fusion is beyond the scope of this discussion, but rely on standard molecular biology techniques such as those described in (11, 12) . After digestion with restriction enzymes, the PCR product is ligated into the pGEX vector and transformed into an E. coli host. Several of the transformants should be grown in mini-culture preparations to check for expression of the target protein. Glycerol stocks of the bacterial culture should be prepared for storage at −80 °C. Once positive expression is confirmed, DNA sequencing should be performed to ensure no errors were introduced during the PCR amplification or ligation.
Cloning the GST fusion protein
1. Amplify the target protein sequence by PCR. Be sure to introduce restriction sites at the ends of the target gene fragment that are in-frame and complementary to the vector chosen.
2.
Digest the PRC product and the chosen vector with compatible restriction enzymes.
3.
Clean digested products by gel electrophoresis followed by a PCR clean-up kit (i.e., Qiagen).
4.
Ligate then transform into appropriate, competent E. coli cells (see Note 2). Grow transformants overnight at 37 °C on LB agar plates supplemented with ampicillin.
5.
Screen several colonies to verify that the insert is in the proper orientation and in the correct reading frame. Transfer several single colonies to separate tubes containing resuspended Ready-to-Go-PCR beads with 10 pmol each pGEX 5′ and 3′ sequencing primers added. After transferring the colony, streak some of the remaining bacteria on an LB agar plate. This can be used as a source for the miniprotein expressions. Overlay with mineral oil and perform PCR. Analyze 10 μl each by agarose gel electrophoresis.
6.
Select several individual colonies that are positive by PCR and grow a separate 5 ml mini-culture of each selected transformant to screen for expression of the target protein (see Note 6).
7.
Glycerol stocks may be prepared by mixing equal volumes of log phase bacterial culture and 70% glycerol. Invert several times to mix. Store at −80 °C.
8.
Verify the integrity of the target gene sequence by DNA sequence analysis.
Expression of GST fusion protein
One of the driving forces behind the development of the GST fusion system is that the GST protein accumulates in the cytoplasm (1) and, due to the large size of this affinity tag, it is expected that the solubility of the GST moiety would usually propagate to the fusion partner -thereby eliminating the need for lengthy purification schemes for insoluble proteins that usually involve denaturants. Unfortunately, in practice, it is unpredictable which fusion proteins will remain soluble and which will accumulate in occlusion bodies. As a general rule of thumb, the larger the protein and the more complex folding it must undergo, the more likely it will accumulate in inclusion bodies. In most cases, where the fusion protein is initially observed primarily in inclusion bodies, it is desirable to modify culture conditionssuch as lowering growth temperature, increasing aeration, or altering induction conditions to -attempt to obtain soluble protein, rather than to solubilize inclusion bodies with denaturants and refold the protein after extraction. Hence, before conducting a large-scale protein expression it is recommended to complete a pilot experiment to check solubility (see Note 7) . Since the main determinant of successful purification of functional GST fusion proteins in good yields is protein solubility, it is worth the effort to optimize culture conditions prior to large-scale purification experiments (see Note 8) .
Yields of GST fusion proteins using expression in E. coli are highly variable, often ranging from 10 to 50 mg/liter, but could potentially be much lower in cases where the fusion protein is toxic to the cells or unstable (see Note 9) . Since expression levels are typically high, adequate amounts of protein usually can be obtained from several liters or less of bacterial culture grown in shaker flasks. The following protocol describes protein production at 37 °C; however, exact temperature and induction conditions for each construct should be modified to improve the yield of soluble protein. Cell density can be monitored using A 600 (see Note 10) and protein expression can be analyzed using SDS-PAGE of un-induced and induced samples (see Note 6) . Once the culture has been induced with IPTG, do not allow 6 Following is a screening protocol to check protein expression levels of fusion protein in mini-cultures. The presence of an increase in protein levels at the expected molecular weight on an SDS-PAGE gel after induction with IPTG is a good indication of successful protein expression. After induction, a prominent band at the expected molecular weight (molecular weight of target protein + ~ 26 KDa for the GST moiety) should be visible. If it is suspected that the protein is expressed at a low level, verification of correct expression can be accomplished using Western blotting with an antibody specific for either the target protein or GST. If the samples will not immediately be analyzed by SDS-PAGE, they may be stored overnight at 4 °C or at −20 °C for longer-term storage.
a. Inoculate several isolated colonies into separate 50 ml centrifuge tubes containing 10 ml LB supplemented with 100 μg/ml ampicillin. Grow an overnight culture at 37 °C with shaking.
b. The next morning, add 0.5 ml overnight culture to 4.5 ml LB with 100 μg/ml ampicillin. Grow 1 h at 37 °C.
c.
Remove 1 ml of un-induced sample. Centrifuge and remove supernatant. Freeze or store on ice until ready to run SDS-PAGE.
d. Add IPTG to a final concentration of 1 mM and grow for an additional 2-3 h. If the sample is present primarily in the lysate and resuspended pellet, the sample is most likely in occlusion bodies. In cases where the protein is located in inclusion bodies, explore different expression conditions to shift expression to a soluble form (see Note 8) . 8 If the fusion protein is expressed primarily in inclusion bodies (e.g. >80% insoluble), various strategies may be employed to improve solubility. Often, induction at lower temperature (15-25 °C) is effective at shifting expression from inclusion bodies to the soluble fraction. Cells induced at this lower temperature will grow more slowly and will require overnight induction periods. Use of alternative host strains or modifications to the plasmid construct may be necessary in some cases. If the fusion protein remains primarily in inclusion bodies even after attempts to obtain soluble protein, it may be worthwhile to scale up the production of E. coli and purify enough protein from the small amount of soluble protein that is available. In some cases, other fusion protein tags should be explored. 9 Low protein expression levels could be the result of rare codon usage. In this case, switching to another strain of E. coli that contains extra transcripts for rare codon tRNA can improve significantly protein production. Different media formulations or addition of up 2% glucose also may improve expression (13, 14) . If it is suspected that the expressed protein is toxic to the cells (usually they will stop growing after induction with IPTG), try inducing at a later time point for a shorter amount of time. Decreasing the IPTG concentration is another option that should be explored.
the cells to grow for extended periods of time, as cell lysis can occur and release proteases into the cytoplasm that could degrade the fusion protein.
1. Using sterile technique, transfer some of a glycerol culture or isolated colonies grown on a streaked plate to 100 ml LB with 100 μg/ml ampicillin.
2.
Incubate the inoculated culture overnight at 37 °C, with shaking at 250-300 rpm.
3. The next morning remove a 1 ml aliquot of cells and check the OD 600 using a spectrophotometer (see Note 10).
4.
Using sterile technique, dilute the overnight starter culture 1:20 into 600 ml fresh LB supplemented with 100 μg/ml ampicillin (see Note 11).
5.
Incubate the culture at 37 °C at 250-300 rpm until the OD 600 is 0.5-0.7 (see Note 10).
6.
Remove a 1 ml aliquot of cells to be saved for gel analysis (see Note 6).
7.
Add IPTG to a final concentration of 1.0 mM final concentration.
8.
Incubate at 37 °C at 250-300 rpm for an additional 3 h (see Note 10), while monitoring the growth at OD 600 . At saturation they will stop dividing. Remove 1 ml aliquot of cells for gel analysis (see Note 6).
9.
Harvest cells by centrifugation at 4000 × g for 20 min at 4 °C.
10.
Carefully decant the supernatant, leaving ~ 15-50 ml in the centrifuge bottle.
11.
Resuspend the cells and transfer to a 50 ml centrifuge tube.
12.
Centrifuge 20 min at 4000 × g, 4 °C.
13.
Decant the supernatant.
14.
Cell pellet may be frozen for up to several months at −80 °C.
15.
Analyze un-induced and induced samples by SDS-PAGE to check protein expression levels (see Note 6).
Affinity purification of GST fusion protein
Soluble GST fusion proteins are purified easily using an immobilized glutathione Sepharose column. There are several options of immobilized glutathione chromatography media available to purify soluble GST fusion proteins from bacterial cell lysates (see Note 3). The protocol described below is an adaptation of the manufacturer's recommendation using glutathione Sepharose 4B poured into a column and using a peristaltic pump to control flow rates. Protease inhibitors and reducing agents should be added to the buffers, as required, to minimize proteolysis of the fusion protein. An exception is that serine protease inhibitors must be removed from the glutathione buffer prior to enzymatic removal of the GST moiety, as they will inhibit enzyme activity (see Note 12) . Save a small aliquot from each step of the purification for analysis by SDS-PAGE to monitor the location of the fusion protein throughout the purification (see Notes 13 and 14 ). A given column or batch of resin should be used exclusively with a single fusion protein to minimize potential cross contamination. As an alternative to column purification, a protocol describing batch purifications is described in Note 15. Batch purifications are quick and simple, but frequently the yield and purity of the protein obtained will be somewhat lower than that obtained through chromatographic separations. In order to minimize proteolysis, all steps of the protein purification should be carried out at 4 °C, unless otherwise noted.
1.
Resuspend and pour 20 ml glutathione Sepharose 4B resin into a 2.5 × 8 cm column (see Note 16 and 17 ).
2.
Thoroughly wash the glutathione Sepharose with 5-10 bed volumes (see Note 16) PBS at 1.5 ml/min to remove the ethanol storage solution.
3.
Resuspend the pelleted E. coli cells in 15 ml cold lysis buffer (cells might be freshly prepared or thawed frozen cell pellets) (see Note 18).
4.
Lyse cells by sonication on ice (~10 times for 10 sec each with 1 min rest between bursts to minimize sample heating). Save 50 μl of lysate for gel analysis and transfer remainder to 60 ml centrifuge tube (see Note 19) .
5.
Centrifuge the lysate at 48,000 × g for 20 min at 4 °C.
6.
Decant the supernatant into a clean 50 ml centrifuge tube. 12 It is important that no serine protease inhibitors be present in the sample prior to cleavage with thrombin or factor Xa. The following protease inhibitors must be removed prior to thrombin or factor Xa cleavage: AEBSF, APMSF, antithrombin III, antipain, α 1 -antitrypsin, aprotinin, chymostatin, hirudin, leupeptin, and PMSF. In addition, Pefabloc TH benzamidine is specific for thrombin, and Pefabloc FXa is specific to factor Xa. The following protease inhibitors should be avoided with PreScission Protease: 100 mM ZnCl 2 , 100 μM chymostatin, and 4 mM Pefabloc. 13 There are a number of alternative methods for detection of GST fusion proteins. For proteins that express well at a high level, the simplest method of monitoring the purification is via SDS-PAGE gels stained with Coomassie blue or silver stain. An alternative for proteins that express at low levels is to use Western blotting using an antibody directed at either GST or the target protein. An alternative for small-scale expressions is to monitor for the presence of GST with an ELISA or CDNB enzyme assay. 14 Save a small amount of protein sample from each step of the purification, including lysis, supernatant, pellet, unbound fractions from sample loading, wash steps, and elution steps to be analyzed by SDS-PAGE or Western blotting. After all samples have been analyzed and pooled, discard unwanted fractions. 15 GST proteins also can be purified using a batch purification method. A batch purification method is quick, easy, and requires little equipment; however, the resulting protein may contain more impurities and have a lower yield than a chromatography-based purification. Batch purifications are best utilized when screening purification conditions. The batch purification outlined below is generally performed at room temperature. To minimize the risk of proteolytic degradation, the procedure can be performed at 4 °C by increasing the incubation time 2-to 4-fold.
a. Lyse cells and obtain soluble fusion protein (see Notes 8 and 21 if sample is in inclusion bodies).
b. Add 2 ml 50% slurry glutathione Sepharose bulk matrix (1 ml bed volume) per 100 ml bacterial lysate supernatant. Incubate 30 min at room temperature with gentle agitation.
c.
Centrifuge 500 × g for 5 min. Remove the supernatant and save for analysis by SDS-PAGE to determine binding efficiency.
d. Wash the resin with 10 bed volumes PBS. Gently resuspend, and then centrifuge 500 × g for 5 min. Remove the supernatant. Repeat wash and centrifugation steps for a total of 3 washes of 10 bed volumes each.
e.
Elute the fusion protein by resuspending the resin with 1.0 ml glutathione elution buffer per ml bed volume. Incubate 10 min at room temperature. Centrifuge 500 × g for 5 min. Transfer the fusion protein-containing supernatant to a separate tube. Repeat elution and collection steps a total of 3 times. The supernatants may be pooled or analyzed separately by SDS-PAGE to monitor protein content (see Note 12 
7.
Resuspend the pellet in 15 ml PBS buffer using a dounce homogenizer (see Note 18).
8.
Run 5-10 μl each of lysate, supernatant, and resuspended pellet on an SDS-PAGE gel to verify that the fusion protein is in the supernatant fraction (see Note 7) . If the fusion protein is located in the pellet fraction, see Note 8 for tips to improve soluble protein expression or Note 20 for methods of extracting the protein from inclusion bodies.
9.
Load the soluble fusion protein to the equilibrated glutathione Sepharose column using a flow rate of 0.1 ml/min (see Notes 21 and 22 ). Collect fractions and run gels to verify that fusion protein is binding to the column and that the capacity has not 19 Cell disruption is complete when the suspension partially clears and turns a slightly darker color. Avoid frothing during sonication, as this can lead to denaturation of the fusion protein. Avoid oversonication, as this can lead to co-purification of host E.coli proteins along with the GST fusion protein. High viscosity due to release of nucleic acids during sonication can be reduced by adding DNase or benzoase to the lysis buffer. Lysozyme up to a concentration of 0.2 mg/ml may be added as an aid to cell lysis. An alternative to sonication is the use of commercially available cell-extraction formulations. However, these products could contain proprietary components that interfere with downstream applications. 20 If attempts to shift expression from inclusion bodies to the soluble fraction fail, insoluble GST fusion proteins sometimes can be purified in the presence of denaturants such as urea, followed by refolding. Solubilization using detergents such as sarkosyl (Nlaurylsarosine) also has been successfully employed (15, 16) . Although the following protocol has been used successfully to denature and re-nature GST fusion proteins, each fusion protein construct is unique and the exact denaturation and re-naturation conditions must be determined empirically. Common denaturants that have been successfully employed include guanidine HCl, urea, Tween 20, CTAB, and SDS (17, 18) . The denaturants then must be completely removed to allow proper refolding of the protein. Conditions that should be optimized to facilitate refolding include: type of denaturant, pH, presence of reducing agent, speed of denaturant removal, and protein concentration. Once the protein has been re-natured, verify that the protein has regained its native conformation and function and remove any improperly folded protein. b. Centrifuge 20 min at 48,000 × g (4 °C). Transfer the supernatant that contains the denatured fusion protein to a clean centrifuge tube.
c.
Add Triton X-100 to the supernatant to a final concentration of 1%.
d. Dialyze the sample into PBS/glycerol for 2-3 h. The volume of the dialysis buffer should be a minimum of 20 times the sample volume.
e.
Dialyze the sample overnight versus PBS with protease inhibitors using a buffer volume that is >100 times the sample volume.
f.
Remove the sample from dialysis and centrifuge 20 min at 4,000 × g.
g.
Extracted and re-natured protein from the inclusion bodies now can be applied to glutathione Sepharose columns and purified.
Solutions:
Wash buffer: 50 mM Tris, 5 mM EDTA, 1 μg/ml leupeptin, 1 μg/ml pepstatin, 0.15 mm PMSF, pH 8.0 U buffer: 5 M urea, 50 mM Tris, 5 mM EDTA,5 mM 2-ME, 1 μg/ml leupeptin, 1 μg/ml pepstatin, 0.15 mM PMSF, 1 mM DFP pH 8.0 PBS/glycerol: 1X PBS, 20% glycerol, 1% Triton X-100, 5 mM 2-ME, 5 mM EDTA, 5 mM 2-ME, 1 μg/ml leupeptin, 1 μg/ml pepstatin, 0.15 mM PMSF, 1 mM DFP pH 7.4 21 Use of a peristaltic pump is advised to evenly control flow rates. If compression of the resin occurs, the pressure is too high and the flow rate should be reduced. 22 The binding kinetics between glutathione and GST are relatively slow. Therefore it is important to use low flow rates to achieve maximum binding capacity, e.g. 0.1 ml/min for a 2.5 cm I.D. column. Using flow rates that are too fast may decrease the amount of bound fusion protein due to the slow kinetics of association. Washing and elution steps may be performed at faster flow rates to save time (1.5 ml/min and 0.3 ml/min, respectively). For large volume samples, binding is most conveniently performed overnight, with adjustments to flow rates so that the column does not run dry.
been exceeded (see Notes 23). If the fusion protein binds poorly to the resin, see Notes 24 for several possible remedies.
10.
Wash the column with 5-10 bed volumes of PBS/EDTA/PMSF using a flow rate of 1.5 ml/min.
11.
Wash the column with 10 bed volumes of PBS/EDTA using a flow rate of 1.5 ml/ min (see Note 12).
12.
Elute the fusion protein with glutathione buffer using a flow rate of 0.3 ml/min. Fractions may be monitored using A 280 and analysis by SDS-PAGE (see Note 25). Pool fractions that contain the GST fusion protein. Protein may be stored at 4 °C and should be ~90% pure at this stage. If problems are encountered eluting the fusion protein, see Note 26. If high levels of contamination are present, see Note 27 for troubleshooting tips.
Enzymatic cleavage to remove GST affinity tag
Depending on the vector chosen, the GST affinity tag can be removed with thrombin, factor Xa, or PreScission protease, either in solution or while still bound to the column matrix. Cleavage in solution offers the advantage of more control over optimization of the cleavage conditions such as temperature, enzyme-to-substrate ratio, length of incubation, and buffer conditions. An advantage of on-column cleavage is the high level of purity obtained, but this comes at the expense of generally low yield due to less efficient protease cleavage and decreased control of the digestion conditions. Digestion can be performed in the glutathione buffer used to elute the protein from the affinity matrix provided there are no serine protease inhibitors in this buffer. After incubation, the enzyme can be inhibited using a variety of protease inhibitors or removed using a HiTrap Benzamidine column. Separation of the target protein and the GST moiety can be achieved by re-chromatography on the glutathione Sepharose column (after dialysis to PBS buffer) to remove the GST and any un-cleaved fusion protein. See Note 28 for digestion of GST fusion proteins while bound to the column matrix (this is recommended for use with PreScission protease).
1.
Add the appropriate amount of thrombin or factor Xa to the affinity-purified fusion protein and incubate at 37 °C (thrombin) or 25 °C (factor Xa) for the desired length of time (see Note 30).
23 Analysis of the unbound fractions will indicate whether the fusion protein is binding or not. If the protein is not detected in early fractions but appears in later fractions, it indicates that the column capacity has been exceeded. Reduction in protein load or increase in column size will alleviate this condition. 24 If the fusion protein binds poorly to the glutathione Sepharose, there are several alternatives to try increasing binding efficiency. Try a milder lysis method. If the method used is too harsh, the protein may become denatured and, therefore, unable to bind to the column. Also, if re-naturing the protein from inclusion bodies, be sure that all denaturants have been removed from the buffer, either through exhaustive dialysis or application of the sample to a desalting column, before applying to the glutathione column. Remove the ethanol storage solution from the glutathione Sepharose; reduce the column with fresh glutathione buffer followed by a wash with PBS immediately prior to sample loading. Increase the amount of resin and/or decrease the flow rate used for loading the sample. Try adding 1-20 mM DTT to the sample. If a problem still persists, clean the column according to the manufacturer's recommendation. If binding still is not restored, try using fresh resin. 25 The yield of fusion protein also can be estimated by measuring absorbance at 280 nm (A 280 ). The extinction coefficient for the GST moiety alone is ~ 1.5, i.e., 1.00 A 280 = ~ 0.6 mg/ml protein, although the extinction coefficient for the fusion protein will depend partially on the absorbance characteristics of the target protein.
26 If there is a problem eluting the protein from the glutathione Sepharose column, try decreasing the flow rate and increasing the volume of elution buffer that is used. Be sure to use fresh reduced glutathione buffer (make it the day that it will be used). Increase the concentration of glutathione up to 40 mM and/or raise the pH of the buffer to pH 8.0-9.0. Add 1-20 mM DTT (or other reducing agent) to the buffer. Addition of a nonionic detergent also may improve solubilization and minimize any aggregation that may be occurring. 27 Contamination of the purified fusion protein with E. coli host cell proteins is an indication that sonication has been too severe. If degraded fragments of the fusion protein are present, try adding additional protease inhibitors to the lysis buffer. Keep all samples, buffers, and collection tubes cold to minimize proteolysis. If degradation is occurring during protein expression, try inducing the sample late (~0.8 OD 600 ) and decrease the length of the induction period. Switching to an alternative host strain also may help.
2.
Inactivate the enzyme by adding 0.3 mM PMSF (final concentration) to the sample. To ensure complete inhibition, incubate the sample 15 min at 37 °C for thrombin or 30 min at 25°C for factor Xa (see Note 32).
3.
Dialyze the sample against PBS/EDTA/PMSF twice using 2L per dialysis for a minimum for 4 h for each dialysis (see Note 33).
4.
Centrifuge the dialyzed sample 20 min at 4,000 × g to remove any precipitated material that may have formed during the digestion or dialysis steps. At this point, the sample can be reapplied to the glutathione Sepharose column to remove the GST moiety and any undigested fusion protein.
Removal of GST affinity tag after protease cleavage in solution
If the protein was digested in solution, the target protein can be purified further by rechromatography on the glutathione Sepharose column to remove any un-cleaved fusion protein and the GST moiety. After a dialysis step to remove the glutathione present from the initial isolation, the sample is reapplied to the column and the sample of interest and thrombin is located in the column flow through. Protein purification should be performed at 4 °C to minimize degradation of the target protein.
1. If reusing a glutathione Sepharose column, wash with > 3 bed volumes of glutathione buffer at 1.5 ml/min (see Note 34 and 35 ).
2.
Wash the glutathione Sepharose column with 10 bed volumes PBS at 1.5 ml/min.
3.
Load the dialyzed, cleaved, fusion protein onto the column at 0.1 ml/min (see Note 22). Collect fractions for analysis by SDS-PAGE (see Note 36).
4.
Wash the column with 2-3 bed volumes PBS/EDTA/PMSF at 1.5 ml/min. 28 An alternative to in-solution digestion is protease cleavage of fusion protein while bound to the glutathione Sepharose matrix. The fusion protein is extracted and loaded onto the glutathione Sepharose followed by washing with PBS (see Affinity purification of GST fusion protein, steps 1-11). Rather than elute the protein with glutathione buffer, a PBS solution containing the enzyme is loaded onto the column and incubated for several hours at room temperature (4 °C for PreScission protease). The cleaved protein then is washed out of the column with several column volumes of PBS. Residual fusion protein and the GST moiety can be removed from the column by washing the column with reduced glutathione buffer. The amount of enzyme and incubation time must be empirically determined for each fusion protein. Analyze all samples by SDS-PAGE to determine cleavage efficiency and protein purity. 30 If using thrombin protease, digestion can be carried out in the glutathione buffer used to elute the protein from the column. If using factor Xa, it is recommended to dialyze the protein into either a Tris buffer or PBS buffer prior to digestion; the glutathione present in the elution buffer can disrupt the disulfide bridges present in factor Xa leading to inefficient digestion of fusion protein. An empirical determination of digestion conditions for each fusion protein must be determined in a pilot digestion experiment. A convenient method is to digest 100 μg of fusion protein over a range of enzyme-to-substrate ratios and vary the incubation time. Typical incubation times range from 2 to 8 hr. Recommended enzyme-to-substrate ratios for thrombin are 1:100, 1:350, 1:1000, and 1:3000 (units of enzyme per μg of fusion protein), and for factor Xa are 1:10, 1:25, 1:50, 1:100, 1:300 (μg enzyme per μg fusion protein). At desired time points, remove 2 μg of protein and stop digestion by adding the sample aliquot to boiling SDS sample buffer. Analyze the samples by SDS-PAGE to determine the optimal cleavage conditions. In addition to enzyme-to-substrate ratio and time, consider altering buffer conditions, such as increasing or decreasing NaCl concentration or adding Ca 2+ to the buffer (see Note 31 for troubleshooting tips). 32 If inhibition of the enzyme after digestion is complete using serine protease inhibitors is undesirable, the sample may be applied to a HiTrap benzamidine column to remove the enzyme from the sample. 33 If the sample is to be re-chromatographed on the glutathione Sepharose column to remove GST and any undigested fusion protein, it is critical that the reduced glutathione be removed completely from the sample. Glutathione equilibrates very slowly across dialysis membranes; therefore if dialysis tubing with a MWCO <12,000 is used, 3 or more changes of buffer may be required for complete removal. Increased dialysis time (overnight) and a larger volume of buffer also may be required for large sample volumes. 34 The same glutathione Sepharose column may be used for both initial isolation of the fusion protein and for repurification after enzymatic cleavage. It is recommended to dedicate a single column to an individual protein construct to avoid potential cross contamination of different recombinant proteins. Columns may be reused multiple times. If binding efficiency decreases over time, clean the column according to the manufacturer's recommendations. If binding activity is not restored, a new column should be used. 35 Maximal binding occurs if the column is fully reduced; however, if the glutathione Sepharose column has been washed less than 48 h prior to this step, this step may be skipped. 36 The target protein will be in the unbound fraction and the GST and any un-cleaved fusion protein will bind to the column.
Figure 1.
Flow diagram illustrating the key decision-making steps for designing and executing a successful GST fusion protein purification. Selection of the vector depends on whether the GST moiety ultimately will be cleaved away and the enzyme that will be used. The insert should be compatible with the vector chosen. A variety of host cells are available; the use of BL21 strains and their derivatives are recommended. Expression conditions should be optimized to yield the highest level of soluble fusion protein. Exact compositions of lysis and purification buffers depend largely on target protein characteristics and should be modified accordingly. Conditions for removal of the GST moiety also will need to optimized. Overall, each step involves multiple options that should be tailored to the characteristics of the target protein and intended purpose of the purified protein. GST fusion proteins may be constructed using one of 10 different pGEX vectors. Shared characteristics of the vectors include a gene for ampicillin resistance; the laqI q gene product is a repressor protein which binds to the operator region of the Ptac promoter preventing expression of protein product until induction with IPTG. The gene for the protein of interest can be inserted in the polylinker site immediately after the GST gene. The protease cleavage sites are located between the GST moiety and the protein of interest. Although not shown for all vectors, stop codons in all three reading frames follow the polylinker site. A consideration to be made when selecting the vector is to minimize the number of amino acids remaining after proteolytic cleavage. (© 2009 General Electric Company -Reproduced by permission of the owner)
